Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine

BACKGROUND: Over-expression of thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) in tumor tissue is associated with insensitivity to 5-fluorouracil (5-FU). Over-expression of ERCC1 correlates with insensitivity to oxaliplatin (OX) therapy, while high thymidine phosphorylase (TP) le...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida, Kazumi, Danenberg, Peter V, Danenberg, Kathleen D, Grem, Jean L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637882/
https://www.ncbi.nlm.nih.gov/pubmed/19105824
http://dx.doi.org/10.1186/1471-2407-8-386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637882/
https://www.ncbi.nlm.nih.gov/pubmed/19105824
http://dx.doi.org/10.1186/1471-2407-8-386

Ejemplares similares